| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |